These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 33559726

  • 1. Intra-abdominal lymphatic malformation management in light of the updated International Society for the Study of Vascular Anomalies classification.
    Elbaaly H, Piché N, Rypens F, Kleiber N, Lapierre C, Dubois J.
    Pediatr Radiol; 2021 May; 51(5):760-772. PubMed ID: 33559726
    [Abstract] [Full Text] [Related]

  • 2. A multidisciplinary approach to management of abdominal lymphatic malformations.
    Zamora AK, Barry WE, Nowicki D, Ourshalimian S, Navid F, Miller JM, Zeinati C, Anselmo DM.
    J Pediatr Surg; 2021 Aug; 56(8):1425-1429. PubMed ID: 33526253
    [Abstract] [Full Text] [Related]

  • 3. Ultrasonographic diagnosis, classification, and treatment of cervical lymphatic malformation in paediatric patients: a retrospective study.
    Li J, Zhong W, Geng X, Liu X, Zhang X, Wang Y, Li H.
    BMC Pediatr; 2020 Sep 19; 20(1):441. PubMed ID: 32950065
    [Abstract] [Full Text] [Related]

  • 4. Bowel perforation following percutaneous sclerotherapy of an intra-abdominal lymphatic malformation.
    Durand RE, Heye P, Cahill AM, Laje P, Srinivasan AS.
    Pediatr Radiol; 2022 Jul 19; 52(8):1592-1595. PubMed ID: 35445817
    [Abstract] [Full Text] [Related]

  • 5. Symptom Resolution and Volumetric Reduction of Abdominal Lymphatic Malformations With Sclerotherapy.
    Madsen HJ, Annam A, Harned R, Nakano TA, Larroque LO, Kulungowski AM.
    J Surg Res; 2019 Jan 19; 233():256-261. PubMed ID: 30502256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
    Zobel MJ, Nowicki D, Gomez G, Lee J, Howell L, Miller J, Zeinati C, Anselmo DM.
    J Pediatr Surg; 2021 May 19; 56(5):1062-1067. PubMed ID: 33982660
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
    Hill RH, Shiels WE, Foster JA, Czyz CN, Stacey A, Everman KR, Cahill KV.
    Ophthalmic Plast Reconstr Surg; 2012 May 19; 28(2):119-25. PubMed ID: 22366666
    [Abstract] [Full Text] [Related]

  • 9. Lymphatic malformations.
    Kulungowski AM, Patel M.
    Semin Pediatr Surg; 2020 Oct 19; 29(5):150971. PubMed ID: 33069296
    [Abstract] [Full Text] [Related]

  • 10. Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.
    Puccia R, Staricha K, Carlberg VM, Moe D, Chun R.
    Int J Pediatr Otorhinolaryngol; 2020 Nov 19; 138():110388. PubMed ID: 33152979
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN, Nag U, Shortell CK.
    J Vasc Surg Venous Lymphat Disord; 2020 Nov 19; 8(6):1074-1082. PubMed ID: 32284312
    [Abstract] [Full Text] [Related]

  • 13. Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.
    Sadick M, Müller-Wille R, Wildgruber M, Wohlgemuth WA.
    Rofo; 2018 Sep 19; 190(9):825-835. PubMed ID: 29874693
    [Abstract] [Full Text] [Related]

  • 14. Sclerotherapy for intra-abdominal lymphatic malformations in children.
    Russell KW, Rollins MD, Feola GP, Arnold R, Barnhart DC, Scaife ER.
    Eur J Pediatr Surg; 2014 Aug 19; 24(4):317-21. PubMed ID: 23846982
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
    Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM.
    J Neurointerv Surg; 2014 Nov 19; 6(9):691-4. PubMed ID: 24153336
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants ≤12 months of age.
    Caton MT, Duvvuri M, Baker A, Smith ER, Narsinh KH, Amans MR, Hetts SW, Higashida RT, Cooke DL, Dowd CF.
    J Neurointerv Surg; 2023 Dec 19; 15(12):1242-1246. PubMed ID: 36414388
    [Abstract] [Full Text] [Related]

  • 17. Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations.
    Giet L, Evans N, Papadopoulou A, Khalifa M, Tsui J, Hamilton G, Brookes J, Lim CS.
    J Vasc Surg; 2021 May 19; 73(5):1794-1799. PubMed ID: 33075453
    [Abstract] [Full Text] [Related]

  • 18. Vascular Anomaly Syndromes in the ISSVA Classification System: Imaging Findings and Role of Interventional Radiology in Management.
    Wang MX, Kamel S, Elsayes KM, Guillerman RP, Habiba A, Heng L, Revzin M, Mellnick V, Iacobas I, Chau A.
    Radiographics; 2022 Oct 19; 42(6):1598-1620. PubMed ID: 36190850
    [Abstract] [Full Text] [Related]

  • 19. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
    Ghaffarpour N, Petrini B, Svensson LA, Boman K, Wester T, Claesson G.
    Acta Paediatr; 2015 Nov 19; 104(11):1169-73. PubMed ID: 26081020
    [Abstract] [Full Text] [Related]

  • 20. Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations.
    Caton MT, Baker A, Smith ER, Perez E, Hemphill K, Cooke DL, Dowd CF.
    J Neurointerv Surg; 2023 Sep 19; 15(9):931. PubMed ID: 35977819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.